Critical Role of Pathologists in the Accurate Subclassification of Non-Small Cell Lung Carcinoma (NSCLC) for Targeted Therapies: Evidence- Based Practice and the Role of IHC Markers
*Corresponding Author
:
Qing Kay Li, Associate Professor, Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA, Tel: (410)550-0671, Fax: (410)550-0075, Email: qli23@jhmi.edu
Received Date: Dec 27, 2016 / Accepted Date: Dec 28, 2016 / Published Date: Dec 31, 2016
Keywords: Cancer; Therapy,Biopsies; Heterogeneity; Pathologists; Tumor; Adenocarcinoma; Specificity; Marker
Citation: Li QK (2016) Critical Role of Pathologists in the Accurate Subclassification of Non-Small Cell Lung Carcinoma (NSCLC) for Targeted Therapies: Evidence- Based Practice and the Role of IHC Markers. Diagn Pathol Open 1: e105. Doi: 10.4172/2476-2024.1000e105
Copyright: ©2016 Li QK. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Tools
Article Usage
- Total views: 2910
- [From(publication date): 0-2016 - Sep 19, 2024]
- Breakdown by view type
- HTML page views: 2237
- PDF downloads: 673
